Skip to content

Exploring the clinical efficacy and mechanism of acupuncture for pDOC patients based on neuroelectrophysiological technique

Exploring the clinical efficacy and mechanism of acupuncture for pDOC patients based on neuroelectrophysiological technique

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076180
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of consciousness

Interventions

Observation group:Conventional treatment + acupuncture intervention
Waiting group:Conventional treatment

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?Patients who met the above diagnostic criteria for pDOC were included only in the VS/UWS and MCS stages; ?Those who have a first sudden onset of impaired consciousness with a clear etiology and a complete case history; ?Those without significant hydrocephalus and without severe cerebral atrophy; ?Those who have not used any sedative or antiepileptic drugs in the last 1 week; ?Age is between 18-80 years old and gender is not limited; ?Those without significant pre-morbid cognitive impairment, hearing impairment or visual impairment; ?Those who were able to communicate accurately in Chinese prior to the onset of the disease and had no significant neurologic or psychiatric history; ?Those with stable medical conditions, relatively stable vital signs, and not enrolled in another study within the last 3 months; ?Informed consent was obtained from the subject's legal representative, and the subject's legal representative voluntarily cooperated and signed the informed consent form. Note: Inclusion is only possible if the above criteria are also met.

Exclusion criteria

Exclusion criteria: ?Those who are younger than 18 years of age or older than 80 years of age; ?Combined intracranial tumors, severe hydrocephalus, those with episodes of intracranial infections or brain death, and those with other space-occupying diseases that significantly affect the study results; ?Those with a history of neurologic or psychiatric disorders or drug abuse prior to brain injury; ?Those who are unstable, whose vital signs are not stable, and who have serious complications in the respiratory and circulatory systems that are not effectively controlled; ?Those who are in the acute phase after the onset of the disease, who have been unconscious for less than 28 days or who have incomplete case information; ?Those with severe endocrine-metabolic disorders or with persistent status epilepticus; ?Pregnancy, combined multiple trauma, limb fractures, or large skin defects; ?Participants in other studies within the last 3 months; ?Subjects whose legal representatives do not agree and are unwilling to cooperate in signing the informed consent form; Note: Where any 1 of the above is met, it is excluded.

Design outcomes

Secondary

MeasureTime frame
Glasgow Coma Scale;Full Outline of Unresponsiveness;Nociception Coma Scale-Revised;Disability Rating Scale;Arousal rate;Efficient;Brainstem Auditory Evoked Potential;Somatosensory Evoked Potential;Mismatch Negativity;P300;Glasgow Outcome Scale-Extended;

Primary

MeasureTime frame
The Coma Recovery Scale–Revised;

Countries

China

Contacts

Public ContactLiu Yiwei

West China Hospital of Sichuan University

rliuyiwei@qq.com+86 181 9082 4889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026